114 related articles for article (PubMed ID: 37975323)
1. Associations between admission levels of multiple biomarkers and subsequent worse outcomes in acute ischemic stroke patients.
Jia WL; Jiang YY; Jiang Y; Meng X; Li H; Zhao XQ; Wang YL; Wang YJ; Gu HQ; Li ZX
J Cereb Blood Flow Metab; 2024 May; 44(5):742-756. PubMed ID: 37975323
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
Li J; Lin J; Pan Y; Wang M; Meng X; Li H; Wang Y; Zhao X; Qin H; Liu L; Wang Y;
J Neuroinflammation; 2022 Jun; 19(1):131. PubMed ID: 35761288
[TBL] [Abstract][Full Text] [Related]
3. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
[TBL] [Abstract][Full Text] [Related]
4. Plasma Human Cartilage Glycoprotein-39 Is Associated With the Prognosis of Acute Ischemic Stroke.
Xu T; Zhang K; Zhong C; Zhu Z; Zheng X; Yang P; Che B; Lu Y; Zhang Y
J Am Heart Assoc; 2022 Sep; 11(18):e026263. PubMed ID: 36102255
[TBL] [Abstract][Full Text] [Related]
5. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
[TBL] [Abstract][Full Text] [Related]
6. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke.
Tsukagawa T; Katsumata R; Fujita M; Yasui K; Akhoon C; Ono K; Dohi K; Aruga T
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2404-2411. PubMed ID: 28645523
[TBL] [Abstract][Full Text] [Related]
8. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke.
Cai Z; He W; Zhuang FJ; Chen Y
Int J Neurosci; 2019 May; 129(5):423-429. PubMed ID: 30332913
[TBL] [Abstract][Full Text] [Related]
9. Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.
Matsuo R; Ago T; Hata J; Wakisaka Y; Kuroda J; Kuwashiro T; Kitazono T; Kamouchi M;
PLoS One; 2016; 11(6):e0156790. PubMed ID: 27258004
[TBL] [Abstract][Full Text] [Related]
10. Association of inflammatory and platelet volume markers with clinical outcome in patients with anterior circulation ischaemic stroke after endovascular thrombectomy.
Chen Z; He Y; Su Y; Sun Y; Zhang Y; Chen H
Neurol Res; 2021 Jun; 43(6):503-510. PubMed ID: 33402058
[No Abstract] [Full Text] [Related]
11. Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry.
Qin H; Liu G; Zhang Y; Zhang J; Wang A; Yu M; Zhang R; Lin J; Liang X; Liu L; Zhang G; Zhao X; Wang Y
Cerebrovasc Dis; 2023; 52(4):460-470. PubMed ID: 36716730
[TBL] [Abstract][Full Text] [Related]
12. Association of High-sensitivity C-reactive Protein with Patient Prognosis Following Mechanical Thrombectomy for Acute Ischemic Stroke.
Kim S; Yi HJ; Lee DH; Sung JH
Curr Neurovasc Res; 2020; 17(4):402-410. PubMed ID: 32416678
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.
Wang C; Gao L; Zhang ZG; Li YQ; Yang YL; Chang T; Zheng LL; Zhang XY; Man MH; Li LH
Mol Neurobiol; 2016 Apr; 53(3):1509-1517. PubMed ID: 25650122
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
Qu X; Shi J; Cao Y; Zhang M; Xu J
Curr Neurovasc Res; 2018; 15(1):10-17. PubMed ID: 29577860
[TBL] [Abstract][Full Text] [Related]
15. Association of circulating high-sensitivity C-reactive protein with late recurrence after ischemic stroke.
Zhang YB; Yin Z; Han X; Wang Q; Zhang Z; Geng J
Neuroreport; 2017 Jul; 28(10):598-603. PubMed ID: 28542069
[TBL] [Abstract][Full Text] [Related]
16. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke.
Jin A; Wang S; Li J; Wang M; Lin J; Li H; Meng X; Wang Y; Pan Y
Stroke; 2023 Mar; 54(3):759-769. PubMed ID: 36722344
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.
Rajeshwar K; Kaul S; Al-Hazzani A; Babu MS; Balakrishna N; Sharma V; Jyothy A; Munshi A
Inflammation; 2012 Jun; 35(3):978-84. PubMed ID: 22038116
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese.
Huang Y; Jing J; Zhao XQ; Wang CX; Wang YL; Liu GF; Wang CJ; Liu LP; Yang XM; Jiao Y; Jiao Y; Wang LS; Wang YJ; Gu WK
CNS Neurosci Ther; 2012 Mar; 18(3):261-6. PubMed ID: 22449109
[TBL] [Abstract][Full Text] [Related]
19. Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
Hu D; Ding C; Jiang X; Xiao J; Li C; Zhang L; Li T; Ji Y; Peng Y; Luo X; Sheng L; Wang Q; Wu H
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105587. PubMed ID: 33450606
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
Li YM; Liu XY
J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
